Compare GSK plc (GSK) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Suncor Energy Inc. — how do they compare? GSK plc trades at $52.48 (market cap $101.34B), while Suncor Energy Inc. trades at $61.1 (market cap $70.89B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | SU | |
|---|---|---|
Market Cap | $101.34B | $70.89B |
Sector | Health | Energy |
52-Week High | $61.18 | $69.73 |
52-Week Low | $36.20 | $38.17 |
Enterprise Value | $121.95B | $79.02B |
Dividend Yield | 3.49% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Suncor Energy (SU) trades at $61.04, down 0.38% on the day, with a bullish technical signal supported by moving averages. The company maintains solid fundamentals with a P/E of 16.37, net income margin of 11.62%, and consistent positive cash flow from operations ($12.78B in 2025). Recent quarterly earnings show a mixed pattern, beating expectations in Q3 and Q4 2025 but missing in Q1 2026, while Q2 2026 results are pending. The stock offers a dividend yield with a recent $0.60 per share payment announced for June 2026.
SU presents a compelling value opportunity with attractive valuation metrics (EV/EBITDA 6.91) and strong analyst support (74% buy ratings). Key opportunities include operational improvements, record production levels, and shareholder returns through dividends. Primary risks involve commodity price volatility, recent operational incidents like the Sarnia refinery fire, and broader energy sector headwinds from potential oil price declines and recession concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
